More articles from Neurosciences

You have access
Precision imaging the association of sex and APOE ε4 with brain tau deposition in individuals with Alzheimer’s disease using ¹⁸F-AV-1451 PET
Shaozhen Yan, Chaojie Zheng, Jian Li, Gengsheng Chen, Zhude Tu, Joel Perlmutter, Tammie Benzinger, Jie Lu and Yun Zhou

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 280;
You have access
Crossed cerebellar diaschisis on ¹⁸F-FDG PET across neurodegenerative diseases: frequency and association with ¹¹C-PIB and ¹⁸F-FTP
Karine Provost, Amelia Strom, Leonardo Iaccarino, Lauren Edwards, Taylor Mellinger, Julie Pham, Suzanne Baker, Bruce Miller, William Jagust, Renaud La Joie and Gil Rabinovici

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 342;
You have access
Tau Accumulation Over One Year Measured with F-18 MK6240 PET.
Christopher Rowe, Vincent Dore, Natasha Krishnadas, Rachel Mulligan, Regan Tyrrell, Samantha Burnham and Victor Villemagne

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 285;
You have access
High sigma-1 receptor (S1R) but minimal dopamine-2 / dopamine-3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers and Huntington disease patients investigated by using (S)-(-)-[¹⁸F]Fluspidine and [¹⁸F]Fallypride PET
Philipp Meyer, Igor Grachev, Georg Becker, Marcus Bronzel, Doug Marsteller, Franziska Zientek, Michael Rullmann, Bernhard Sattler, Marianne Patt, Thilo Gerhards, Andreas Kluge, Peter Brust, Mark Gordon, Michal Geva, Swen Hesse, Henryk Barthel, Michael Hayden and Osama Sabri

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 338;
You have access
Effects of modulating gamma oscillations via 40Hz transcranial alternating current stimulation (tACS) on Tau PET imaging in mild to moderate Alzheimer’s Disease
Maeva Dhaynaut, Davide Cappon, Rachel Paciorek, Joanna Macone, Ann Connor, Nicolas Guehl, Alvaro Pascual-Leone, Georges El Fakhri and Emiliano Santarnecchi

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 340;
You have access
FDG and amyloid PET reflect the neuropathological staging schemes of Braak and Thal
Ganna Blazhenets, Lars Frings, Arnd Sorensen and Philipp Meyer

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 281;
You have access
Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson‘s disease: a longitudinal study
Jingjie Ge, Chuantao Zuo, Ping Wu and Kuangyu Shi

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 341;
You have access
Prediction of conversion of mild cognitive impairment to Alzheimer’s dementia: a comparison of different PET and CSF amyloid markers
Arnd Sorensen, Ganna Blazhenets, Florian Schiller, Philipp Meyer and Lars Frings

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 282;
You have access
Multiple Brain Effects of Pridopidine in Huntington Disease Patients and Healthy Volunteers - A Simultaneous Sigma-1 Receptor PET/MRI Study
Henryk Barthel, Philipp Meyer, Michael Rullmann, Georg Becker, Marcus Bronzel, Doug Marsteller, Franziska Zientek, Bernhard Sattler, Marianne Patt, Andreas Kluge, Juha Savola, Mark Gordon, Michal Geva, Swen Hesse, Michael Hayden, Igor Grachev and Osama Sabri

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 336;
You have access
Dynamic Amyloid-PET/MRI: Relationships to Flortaucipir Uptake in Alzheimer’s Disease
Fabio Raman, Yu-Hua Fang, Sameera Grandhi, Charles Murchison, Richard Kennedy, John Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik Roberson and Jonathan McConathy

Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 283;

Main menu

User menu

Search

More articles from Neurosciences

Pages